Concepedia

Yacine Maringer

YM

Statistics

Publications

16

Citations

1.5K

H-Index

14

Active since

2020

Affiliations

University of Tübingen(Current)

University Children's Hospital Tübingen

Deutsches Konsortium für Translationale Krebsforschung

German Cancer Research Center

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Yacine Maringer is an author at University of Tübingen specializing in life sciences, immunology, and infectious diseases.

ORCID

Publications per year

2020–2024

16

Publications

16

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 641 citations · Full text

, , +14

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler et al. · Nature · 2021 · 275 citations · Full text

, , +17

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich, Annika Nelde, Jonas S. Heitmann et al. · Science Translational Medicine · 2021 · 173 citations · Full text

, , +16

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Jens Bauer, Natalie Köhler, Yacine Maringer et al. · Nature Communications · 2022 · 76 citations · Full text

, , +17

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination

Yacine Maringer, Annika Nelde, Sarah M. Schroeder et al. · Science Immunology · 2022 · 73 citations · Full text

, , +17

1–5 of 16